PRESS RELEASE published on 12/14/2023 at 17:30, 11 months 6 days ago enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium
PRESS RELEASE published on 11/16/2023 at 14:45, 1 year ago enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium
PRESS RELEASE published on 10/26/2023 at 14:05, 1 year ago enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update
PRESS RELEASE published on 10/12/2023 at 15:00, 1 year 1 month ago enVVeno Medical to Participate at the Virtual Investor Ask the CEO Conference
PRESS RELEASE published on 10/06/2023 at 14:57, 1 year 1 month ago enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial
PRESS RELEASE published on 10/06/2023 at 14:56, 1 year 1 month ago enVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous Valve
PRESS RELEASE published on 10/06/2023 at 14:55, 1 year 1 month ago enVVeno Medical Announces Private Placement of $28 Million
Published on 11/21/2024 at 13:00, 39 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 39 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 39 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 39 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 39 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 4 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 24 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 19 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 54 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 54 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
